BioNTech SE (BNTX) Treasury Shares (2019 - 2025)
BioNTech SE (BNTX) posted Treasury Shares of $9.0 million for Q4 2025, up 194.65% sequentially from -$9.5 million in Q3 2025, and down 2.47% YoY from $9.2 million in Q4 2024.
BioNTech SE (BNTX) Treasury Shares (2019 - 2025) Analysis & Trends
BioNTech SE has reported Treasury Shares for 7 years, with the latest figure at $9.0 million in Q4 2025.
- Quarterly Treasury Shares fell 2.47% year-over-year to $9.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.0 million (down 2.47% YoY) and the FY2025 annual result came in at $8.7 million, down 5.34% from the prior year.
- Treasury Shares improved to $9.0 million in Q4 2025 per BNTX's latest filing, from -$9.5 million in the prior quarter.
- Over five years, Treasury Shares peaked at $9.2 million in Q4 2024 and troughed at -$938.4 million in Q3 2022.
- A 5-year average of -$204.5 million and a median of -$9.6 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares sank 14594.58% in 2023, then soared 101.16% in 2024.
- Over 5 years, Treasury Shares stood at -$4.3 million in 2021, then slipped by 24.39% to -$5.4 million in 2022, then tumbled by 14594.58% to -$794.6 million in 2023, then surged by 101.16% to $9.2 million in 2024, then decreased by 2.47% to $9.0 million in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $9.0 million, -$9.5 million, and -$9.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 8.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.96 Mn |
| Dec 31, 2025 | -8.96 Mn |
| Sep 30, 2025 | -9.47 Mn |
| Sep 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.28 Mn |
| Jun 30, 2025 | -9.28 Mn |
| Mar 31, 2025 | -8.63 Mn |
| Mar 31, 2025 | -8.63 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Sep 30, 2024 | -9.66 Mn |
| Sep 30, 2024 | -9.66 Mn |
| Jun 30, 2024 | -11.63 Mn |
| Jun 30, 2024 | -11.63 Mn |
| Mar 31, 2024 | -11.73 Mn |
| Mar 31, 2024 | -11.73 Mn |
| Dec 31, 2023 | -794.58 Mn |
| Dec 31, 2023 | -794.58 Mn |
| Dec 31, 2023 | -794.58 Mn |
| Dec 31, 2023 | -794.58 Mn |